title: [Aggressive universal calcinosis complicating dermatomyositis].
authors.forename: F
authors.initials: F
authors.lastname: Bayou
authors.forename: C
authors.initials: C
authors.lastname: Belajouza
authors.forename: L
authors.initials: L
authors.lastname: Boussofara
authors.forename: N
authors.initials: N
authors.lastname: Ghariani
authors.forename: M
authors.initials: M
authors.lastname: Denguezli
authors.forename: E
authors.initials: E
authors.lastname: Bouajina
authors.forename: R
authors.initials: R
authors.lastname: Nouira
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002114:Calcinosis / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D003131:Combined Modality Therapy; D017577:Cutaneous Fistula / Q000209:etiology; D003882:Dermatomyositis / Q000150:complications* / Q000188:drug therapy; D004164:Diphosphonates / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000077268:Pamidronate; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D017192:Skin Diseases, Bacterial / Q000209:etiology / Q000517:prevention & control; D040521:Subcutaneous Tissue / Q000473:pathology*
chemical_list: D000900:Anti-Bacterial Agents; D004164:Diphosphonates; D007166:Immunosuppressive Agents; D000077268:Pamidronate